Figure 2From: Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines The p-paxillin/t-paxillin ratio after treatment with single-agent dasatinib. Activation of paxillin (p-paxillin/t-paxillin) was inhibited by the presence of dasatinib at 500 nm in SK-UT-1 (16%); and 30 nm (14%), 100 nm (1%) and 500 nm (3%) in SK-UT-1B.Back to article page